Teva Pharmaceutical Industries Ltd. (TEVA.TV, TEVA), which launched a $40 billion bid for Mylan NV (MYL) in April, plans to increase the value of its offer, Bloomberg News reported Monday, citing people with knowledge of the matter.

Teva's offer is worth $82 a share. Bloomberg reported that a new bid may be worth $86 to $88 a share.

The new offer could be announced this week, Bloomberg reported.

Full story at http://www.bloomberg.com/news/articles/2015-07-06/teva-said-planning-to-raise-mylan-bid-to-86-88-share-this-week

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Août 2024 à Sept 2024 Plus de graphiques de la Bourse Teva Pharmaceutical Indu...
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024 Plus de graphiques de la Bourse Teva Pharmaceutical Indu...